Poor Immune Status and Systemic Disease Are Independently Associated with Mortality in AIDS-Related Kaposi Sarcoma in Nigeria by Agaba, Patricia et al.
 
Poor Immune Status and Systemic Disease Are Independently
Associated with Mortality in AIDS-Related Kaposi Sarcoma in
Nigeria
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Agaba, Patricia, Halima Sule, Raphael Ojoh, Zakary Saidu,
Mohamed Mua’zu, Oche Agbaji, John Idoko, Ernest Ekong,
Robert Murphy, and Phyllis Kanki. 2012. Poor immune status
and systemic disease are independently associated with mortality
in aids-related kaposi sarcoma in nigeria. Infectious Agents and
Cancer 7(Suppl 1): P7.
Published Version doi:10.1186/1750-9378-7-S1-P7
Accessed February 19, 2015 10:31:04 AM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:10054140
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-
of-use#LAAPOSTER PRESENTATION Open Access
Poor immune status and systemic disease are
independently associated with mortality in
AIDS-related Kaposi Sarcoma in Nigeria
Patricia Agaba
1*, Halima Sule
1, Raphael Ojoh
1, Zakary Saidu
1, Mohamed Mua’zu
1, Oche Agbaji
1, John Idoko
1,
Ernest Ekong
2, Robert Murphy
3, Phyllis Kanki
4
From 13th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies
(ICMAOI)
Bethesda, MD, USA. 7-8 November 2011
Background
AIDS-related Kaposi’s sarcoma (AIDS-KS) is the most
common AIDS-associated malignancy and remains a
significant cause of morbidity and mortality in sub-
Saharan Africa. We describe the determinants of mortal-
ity among patients with AIDS-KS in a comprehensive
HIV care and treatment program in Jos, Nigeria.
Material and methods
We collected epidemiologic, clinical, staging and survival
data for 357 patients with a diagnosis of AIDS-KS enrol-
ling for HIV-care at the Jos University Teaching Hospital.
Patients were staged according to the AIDS Clinical Trials
Group (ACTG) criteria, which are based on the evaluation
of tumor extension (T), CD4+ cell count (I), and patient’s
systemic status (S), stratified by good (0) versus poor (1)
risk. Information on survival was obtained through an
active follow-up on verification of vital status of the
patients. Survival analysis was computed by the Kaplan-
Meier method, and the log-rank test was used to test the
difference between subgroups.
Results
During the period of the study (2004-2008), there were
197 women (55.2%) and 160 (44.8%) men with AIDS-
related Kaposi Sarcoma. Their mean age was 37±8 years
and the median follow-up was 15 months (1-49 months).
The median CD4+ and viral load were 107cells/mm³ and
58,561copies/ml respectively at baseline. Only 42 (11.8%)
were on HAART at KS diagnosis, however all patients
were commenced on HAART in line with existing
national guidelines subsequently. 262(74.4%) had poor
immune system status (I1: CD4+<200cells/mm
3), 77.5%
had widespread tumor extension (T1) and 80.2% had sys-
temic disease (S1). Poor immune system (I1) status (AOR
2.07, CI 1.25-3.42, p=0.002) and presence of systemic dis-
ease (S1) (AOR 2.10, CI 1.03-4.28, p=0.004) were inde-
pendently associated with mortality.
Regarding ACTG classification, the 4-year survival rate
was 67% for I0 vs 46% for I1 (p=0.05), 58% for S0 vs
49% for S1 (p=0.41), 60% for T0 vs 46% for T1 (p=0.19).
Conclusion
Poor immune status and systemic disease are indepen-
dent predictors of mortality in patients with AIDS-KS in
Nigeria.
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